AVAILABLE MEDICINE FOR Midostaurin
There are no products to list.
Introduction to Midostaurin
Midostaurin is a multikinase inhibitor used to treat acute myeloid leukemia (AML) and systemic mastocytosis.
Midostaurin is an anticancer medication that was approved for its medical use in April 2017.
How it Works:
Midostaurin inhibits various kinases involved in cell growth and survival, particularly those associated with FLT3 mutations in AML.
Uses:
- FLT3-mutated AML.
- Advanced systemic mastocytosis.
